Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,754 evidence items · page 29 / 71

88 msSDANN was 88 ms in the poorly controlled type 2 diabetes group.

Cameroundiabète de type 2published 2018BMC research noteseurope_pmcdocument of 8 observations

36.5 %The prevalence of hypertension was 36.5% among men in the rural Fulani population of Cameroon aged ≥ 20 years.

Camerounhypertension artérielleobserved 2013published 2017Journal of health, population, and nutritioneurope_pmcdocument of 3 observationsDOI 10.1186/s41043-017-0112-2

39.52 msSDNN was reduced in patients with hyperthyroidism (39.52) compared to controls (63.75), with a p-value of 0.2.

Camerounhyperthyroidismpublished 2018BMC research noteseurope_pmcdocument of 6 observations

24,700,000 IU/mLIn coinfected patients, the median HBV viral load was 2.47 x 10^7 IU/mL.

Camerounhépatite Bpublished 2010BMC Public HealthOpenAlexdocument of 6 observationsDOI 10.1186/1471-2458-10-105

At day 30, all participants were asymptomatic.

CamerounCOVID-19published 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument of 8 observationsDOI 10.1101/2021.07.25.21260838

2.08 genotypes_per_infectionThe multiplicity of infection (MOI) was 2.08 in Mfou, Cameroon.

CamerounpaludismeHAL · Unilimdocument of 106 observations

31.6 %Among hypertensive participants in Cameroon, 31.6% [95% CI 21.0–42.3] were aware of their status during 2011–2018.

Camerounhypertension artérielleobserved 2011-2018published 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165

Cameroon reported both Clade I and Clade II mpox cases.

CamerounClade I · Clade II · mpoxAfrica CDCdocument of 11 observations

6 %Cameroon population has an estimated 6% affected by diabetes.

Cameroundiabète (non précisé)published 2016BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-016-3090-1

36.8 %The prevalence of hypertension among HIV patients in this study was 36.8%.

Camerounhypertension artériellepublished 2022Medicineeurope_pmcdocument of 12 observations

1.36 %In Pouma Health District, the prevalence of epilepsy recorded by the research team was 1.36%.

CamerounépilepsieHAL · Unilimdocument of 53 observations

47.6 %Insulin could be discontinued in 47.6% of insulin-treated patients with adequate glycaemic control (HbA1c 6.7 +/- 1.3%).

Cameroundiabète (non précisé)published 2002Diabetic medicine : a journal of the British Diabetic Associationeurope_pmcdocument of 5 observations

1.3 %Age-standardized prevalence of current wheeze in the previous year was 1.3% to 2.5% in adults in Cameroon.

Camerouncurrent wheezepublished 2004Tropical doctoreurope_pmcdocument of 10 observations

39,000 peopleIn 2013, about 39,000 people in the Africa Region (AFR) suffered from type 1 diabetes.

Cameroundiabète de type 1observed 2013published 2014Diabetes research and clinical practiceeurope_pmcdocument of 14 observations

69.7 %Among 76 patients followed-up at endpoint, 69.7% had viremia <40 copies/ml.

CamerounVIH/sidaobserved 2009-2011published 2013PLoS ONEOpenAlexdocument of 8 observationsDOI 10.1371/journal.pone.0072680

2 %The age-standardized diabetes prevalence using WHO criteria was 2.0% in urban Cameroon.

Cameroundiabète (non précisé)published 1999Diabetes careeurope_pmcdocument of 12 observations

None of the normal subjects had thyroid autoantibodies.

Camerounthyroid autoantibodiespublished 2006Clinical immunology (Orlando, Fla.)europe_pmcdocument of 10 observations

50 %Le PSNLP 2007-2010 visait à réduire de 50 % la morbidité et la mortalité liées au paludisme en particulier dans les populations à risque d’ici 2010.

Camerounpaludismeobserved 2010HAL · Unilimdocument of 98 observations

23 kg/m2The age-standardized mean BMI increased from 23.0 kg/m2 to 23.0 kg/m2 in men in sub-Saharan African countries between 1980 and 2014.

Camerounbody mass indexobserved 2014published 2017International journal of epidemiologyeurope_pmcdocument of 11 observationsDOI 10.1093/ije/dyx078

0.6 %HIV-1 group O prevalence in Cameroon was around 0.6% (95% confidence interval: 0.4–0.8%).

CamerounHIV-1 group Oobserved 2006 to 2013published 2015Infection, genetics and evolution : journal of molecular epidemiology and evolutionary geneurope_pmcdocument of 4 observations

17.7 %Prevalence of type 2 diabetes mellitus in men in Saudi Arabia was estimated at 17.7% in 2000 by the Markov model.

Cameroundiabète de type 2observed 2000published 2014Diabetes research and clinical practiceeurope_pmcdocument of 7 observations

0.8 %The age-standardized diabetes prevalence using WHO criteria was 0.8% in rural Cameroon.

Cameroundiabète (non précisé)published 1999Diabetes careeurope_pmcdocument of 12 observations

17,001 casEntre janvier et juillet 2018, 17 001 cas de paludisme simple ont été testés à Bafia.

Camerounpaludismeobserved janvier à juillet 2018HAL · Unilimdocument of 67 observations

36 %Le paludisme est responsable de 36 % des cas vus en consultation externe au Cameroun selon les rapports d’activités du PNLP de 2006.

Camerounpaludismeobserved 2006HAL · Unilimdocument of 98 observations

3 %Heart failure accounts for 3%-7% of hospital admission in general internal medicine in sub-Saharan Africa.

Camerouninsuffisance cardiaquepublished 2008Vascular health and risk managementeurope_pmcdocument of 3 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.